Related Experiment Videos
Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task
1Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Abstract:
The effects of the nootropic agent 4-hydroxy-2-oxopyrrolidinoacetamide (oxiracetam) on memory and performance impairments induced by scopolamine were evaluated in the Morris water maze task. No effect was seen on the performance of rats when treated with oxiracetam (30 mg/kg, IP) alone. Task performance of scopolamine (0.2 mg/kg, SC)-treated rats was impaired as compared to that of control animals. The behavioral deficits expressed in the task by scopolamine treatment were attenuated by the same dose of oxiracetam.
Insights
Oxiracetam, a nootropic agent, did not affect normal rat performance. However, it significantly improved memory and performance in rats experiencing scopolamine-induced impairments.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Scopolamine is known to induce memory and performance deficits.
- Nootropic agents are investigated for their potential cognitive-enhancing effects.
Purpose of the Study:
- To evaluate the effects of oxiracetam on scopolamine-induced memory and performance impairments.
- To assess the impact of oxiracetam alone on cognitive performance.
Main Methods:
- The Morris water maze task was employed to assess spatial learning and memory.
- Rats were treated with oxiracetam (30 mg/kg, IP) alone, scopolamine (0.2 mg/kg, SC) alone, or a combination of both.
Main Results:
- Oxiracetam administered alone did not alter rat performance in the Morris water maze.
- Scopolamine treatment significantly impaired task performance compared to control animals.
- Oxiracetam administration attenuated the behavioral deficits induced by scopolamine.
Conclusions:
- Oxiracetam demonstrates potential in mitigating scopolamine-induced cognitive impairments.
- The findings suggest a therapeutic role for oxiracetam in conditions involving memory deficits.